Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,General Medicine
Reference29 articles.
1. Flores VA, Pal L, Manson JE (2021) Recommended hormone therapy in menopause: concepts, controversies and approach to treatment. Endocr Rev. https://doi.org/10.1210/endrev/bnab011. (Online ahead of print. PMID: 33858012)
2. Langer RD, Hodis HN, Lobo RA, Allison MA (2021) Hormone replacement therapy - where are we now? Climacteric 24:3–10. https://doi.org/10.1080/13697137.2020.1851183
3. Rossouw JE, Anderson GL, Prentice RL, Writing group for the women’s health initiative Investigators et al (2002) Risks and benefits of estrogen plus progestin for healthy postmenopausal women. JAMA 288:321–33
4. Women’s Health Initiative Investigators. Protocol for the clinical trial and observational study components. Available from: https://www-whi-org.s3.us-west-2.amazonaws.com/wp-content/uploads/Protocol-1993-2005.pdf
5. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL et al (2003) Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 349:523–534